We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
SKIKON.CO

Price
959.70
Stock movement up
+14.80 (1.57%)
Company name
SKAGEN Kon-Tiki A
Exchange
(CO
,
Currency
DKK
)
Markedsværdi
-
Ent værdi
-
Pris/omsætning
-
Pris/bog
-
Udbytte afkast
-
Udbyttevækst
-
Vekst år
-
FCF-udbetaling
-
Efterfølgende P/E
-
Fremtidig P/E
-
PEG
-
EPS-vekst
-
1 års afkast
19.29%
3 års afkast
-
5 års afkast
-
10 års afkast
-
Senest opdateret: 2025-11-25

UDBYTTE

SKIKON.CO betaler ikke udbytte

VÆRDIANSÆTTELSE

Værdiansættelsesforhold

Loading...
Værdiansættelsesforhold-data
Efterfølgende P/E-
Pris til OCF-
Pris til FCF-
Pris til EBITDA-
EV i forhold til EBITDA-

Værdiansættelse (salg/bogført værdi)

Loading...
Værdiansættelse (salg/bogført værdi)-data
Pris til omsætning-
Pris til egenkapital-
EV i forhold til salg-

ØKONOMI

INFORMATION OM AKTIER

Aktiediagram

Loading...
Aktiekurs-data
Åbning961.90
Daglig høj961.90
Daglig lav955.50
Daglig volumen1K
Højeste gennem alle tider1070.92
1 års analytiker estimat-
Beta1.01
EPS (TTM)-
Udbytte pr. aktie0.00
Ex-div dato-
Næste dato for resultatpræsentation-

Nedsidepotensial

Loading...
Nedsidepotensial-data
SKIKON.COS&P500
Nuværende prisfald fra top notering-10.39%-1.80%
Højeste prisfald-36.06%-19.00%
Højeste efterår dato10 Apr 20258 Apr 2025
Gennemsnitlig fald fra toppen-22.23%-2.73%
Gennemsnitlig tid til nyt højdepunkt-6 days
Maks. tid til nyt højdepunkt276 days89 days
OPLYSNINGER OM VIRKSOMHEDEN
SKIKON.CO (SKAGEN Kon-Tiki A) company logo
Markedsværdi
-
Markedsværdi kategori
Small-cap
Beskrivelse
SKAGEN - Kon-Tiki fund is an open-ended equity mutual fund launched and managed by Skagen AS. The fund invests in public equity markets of emerging countries across the globe. It seeks to invest in stocks of companies operating across diversified sectors. The fund invests in stocks of companies across diversified market capitalizations. It invests in value stocks of companies. It benchmarks the performance of its portfolio against the MSCI Emerging Markets Index. SKAGEN - Kon-Tiki fund was formed on April 5, 2002 and is domiciled in Norway.
Personale
0
Investor relationer
-
SEC-indsendelser
Adm. direktør
Land
Denmark
By
Aktietype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...
FORSTÅ FORRETNINGEN
Loading...
NYHEDER OM VIRKSOMHEDEN
Alle nyhederPressemeddelelser
Lysaker, 30 October 2025 Effective from 30 October 2025, SKAGEN AS will be merged into Storebrand Asset Management (Storebrand AM), but despite the structural changes, the same SKAGEN investment team ...
30. oktober 2025
Lysaker, 28 October 2025 The suspension is lifted for the below funds, and the live trading on Nasdaq Copenhagen can resume. Regards Storebrand Asset Management AS Contacts: Henrik Budde Gantzel, Dire...
28. oktober 2025
Lysaker, 28 October 2025 The below funds are suspended from the live trading on Nasdaq Copenhagen due to technical issues which affect NAV calculations, and hence, challenges to provide intrinsic valu...
28. oktober 2025
Lysaker, 27 October 2025 This is a re-submission of the announcement posted at 14:46, with reference to the correct fund (SKAGEN Focus A) at the bottom of this text. With reference to Nasdaq Copenhage...
27. oktober 2025
Lysaker, 27 October 2025 With reference to Nasdaq Copenhagen's rules for issuers of UCITS units, we hereby notify that incorrect intrinsic values were reported on 24 October for SKAGEN Focus A as deta...
27. oktober 2025
The cider brand has added a high-contrast NaviLens QR code to its cans.
9. september 2025
BioReference health, JPMorgan Chase and an Italian fashion retailer are making the job cuts amid market uncertainty
9. september 2025
Temenos also the winner for Bank Deposit Transformation with Credem and listed in the 2025 IDC FinTech Rankings Top 25GRAND-LANCY, Switzerland, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Temenos (SIX: TEMN), ...
9. september 2025
The Management Board of Artea Bankas has approved changes to the management and organizational structure. The Management Board has received a notice from board member Mindaugas Rudys regarding his res...
9. september 2025
Novartis agreed to buy Tourmaline Bio in a roughly $1.4 billion-dollar deal that boosts its cardiovascular drug pipeline with access to the targeted therapy drug pacibekitug. The Swiss pharmaceuti...
9. september 2025
Næste side